| 注册
首页|期刊导航|中国中医药信息杂志|补中益气丸对乙肝病毒相关失代偿期肝硬化患者5年生存率的影响

补中益气丸对乙肝病毒相关失代偿期肝硬化患者5年生存率的影响

李海军 郭志梅 杨新英 孙殿兴

中国中医药信息杂志2017,Vol.24Issue(1):28-31,4.
中国中医药信息杂志2017,Vol.24Issue(1):28-31,4.DOI:10.3969/j.issn.1005-5304.2017.01.008

补中益气丸对乙肝病毒相关失代偿期肝硬化患者5年生存率的影响

Effects ofBuzhong Yiqi Pills on Five-year Survival Rate of HBV-related Decompensated Liver Cirrhosis Patients

李海军 1郭志梅 1杨新英 1孙殿兴1

作者信息

  • 1. 解放军白求恩国际和平医院,河北石家庄 050082
  • 折叠

摘要

Abstract

Objective To explore the effects ofBuzhong Yiqi Pills on HBV-related decompensated liver cirrhosis patients.Methods A total of 176 patients of HBV-related decompensated liver cirrhosis were enrolled in the study from January 2007 to January 2010 and were divided into treatment group (82 cases) and control group (94 cases) according to patient's wishes. Patients in both groups were given antiviral therapy. According to the liver function and complications, patients were given glycyrrhizin to protect liver, Kuhuang Injection to treat jaundice, and spironolactone and furosemide for diuretic treatment. Patients in the treatment group receivedBuzhong Yiqi Pills, one bag for each time, twice a day, four weeks as a treatment session, three sessions each year, with five-year follow-up. Effects ofBuzhong Yiqi Pills on the hepatorenal function, blood coagulation, blood routine, complications and survival rate in patients with decompensated liver cirrhosis were observed.ResultsBuzhong Yiqi Pills could effectively improve the hepatorenal function, blood routine and coagulation disorders of HBV-related decompensated liver cirrhosis patients (P<0.05,P<0.01). The rate of complications with hydrothorax and ascites (46.34% vs. 88.30%), upper gastrointestinal hemorrhage (39.02% vs. 69.15%), infection (31.71% vs. 57.45%), hepatic encephalopathy (23.17% vs. 54.26%), hepatorenal syndrome (6.10% vs. 18.09%) and chronic hepatic failure (9.76% vs. 25.53%) in the treatment group and the control group were with statistical significance (P<0.05,P<0.01). The five-year survival rates were significantly higher in the treatment group (79.27%) compared with the control group (64.89%), with statistical significance (χ2=5.353,P=0.021).ConclusionLong term use ofBuzhong Yiqi Pills can significantly decrease the complications of HBV-related decompensated cirrhosis and improve survival rate of patients.

关键词

补中益气丸/失代偿期/肝硬化/乙肝病毒/生存率/临床研究

Key words

Buzhong Yiqi Pills/decompensation/cirrhosis/chronic hepatitis B/survival rate/clinical study

分类

医药卫生

引用本文复制引用

李海军,郭志梅,杨新英,孙殿兴..补中益气丸对乙肝病毒相关失代偿期肝硬化患者5年生存率的影响[J].中国中医药信息杂志,2017,24(1):28-31,4.

中国中医药信息杂志

OACSCDCSTPCD

1005-5304

访问量0
|
下载量0
段落导航相关论文